Related Experiment Video
Updated: Sep 23, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
Published on: March 19, 2018
Fusion inhibitors
1Scottish National Blood Transfusion Service, LCMV Royal (Dick) Veterinary College, Summerhall, Edinburgh, EH9 1QH, UK. juraj.petrik@snbts.csa.scot.nhs.uk
Abstract:
The majority of current antiviral drugs target viral genome replication (eg, reverse transcriptase inhibitors) or virion maturation (eg, protease inhibitors). Although efficient, these drugs suffer from the quick appearance of drug-resistant mutants and usually do not eliminate the virus completely. Combination therapy may delay but not eliminate the emerging resistant mutants. The continuing search for novel antiviral compounds has been extended to earlier stages of viral replication cycle, such as virus entry. One particular group of entry inhibitors, the fusion inhibitors, interferes with fusion of viral and host cell membranes, a post-attachment process specific for enveloped viruses.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

